The enzyme dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1). Since GLP-1-based therapy is a promising novel treatment of type 2 diabetes, the strategy to ...

Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

“高血糖是病，低血糖要命！”这句话想必大家都听过， 糖尿病 患者都非常重视高血糖的控制，却经常忽视低血糖的危害。殊不知，低血糖也可能导致大脑、心脏等重要脏器受损，引起昏迷、 心律失常 等问题，严重的低血糖有时是致命的！

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of ...

New research presented at the ACG Annual Meeting suggests that GLP-1RAs lower the risk of pancreatic cancer in patients with ...

Trimsulin is a patent-pending, plant-based nutraceutical weight loss program that promotes lasting weight loss by naturally boosting GLP-1 and GIP levels, inhibiting DPP-4 from degrading them, and ...

New study reports protective effect among people with type 2 diabetes Kidney stones and the systemic conditions associated with them have a major impact on health and the economy in the US and ...

Pills like metformin, sulfonylureas, and DPP-4 inhibitors help lower blood sugar, says the expert. Some people may need insulin injections if pills are not enough, especially if their pancreas are not ...

The 12-week human clinical trial began in early June 2024 and set out to investigate if, through these mechanisms of action, ...

November in the case against 10 men accused of conspiring to import a huge quantity of drugs into Ireland last March.The 10 ...

The Democratic Party for the People remains the third-largest opposition party in Japan, but its sharp gains in the Lower ...

The declassification of a top-secret report by Ipid has lifted the lid on the role police allegedly played in the events ...